Stock Research for BCLI

BCLI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BCLI Stock Chart & Research Data

The BCLI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BCLI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BCLI Due diligence Resources & Stock Charts

The BCLI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BCLI Detailed Price Forecast - CNN Money CNN View BCLI Detailed Summary - Google Finance
Yahoo View BCLI Detailed Summary - Yahoo! Finance Zacks View BCLI Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BCLI Trends & Analysis - Trade-Ideas Barrons View BCLI Major Holders - Barrons
NASDAQ View BCLI Call Transcripts - NASDAQ Seeking View BCLI Breaking News & Analysis - Seeking Alpha
Spotlight View BCLI Annual Report - CompanySpotlight.com OTC Report View BCLI OTC Short Report - OTCShortReport.com
TradeKing View BCLI Fundamentals - TradeKing Charts View BCLI SEC Filings - Bar Chart
WSJ View Historical Prices for BCLI - The WSJ Morningstar View Performance/Total Return for BCLI - Morningstar
MarketWatch View the Analyst Estimates for BCLI - MarketWatch CNBC View the Earnings History for BCLI - CNBC
StockMarketWatch View the BCLI Earnings - StockMarketWatch MacroAxis View BCLI Buy or Sell Recommendations - MacroAxis
Bullish View the BCLI Bullish Patterns - American Bulls Short Pains View BCLI Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BCLI Stock Mentions - StockTwits PennyStocks View BCLI Stock Mentions - PennyStockTweets
Twitter View BCLI Stock Mentions - Twitter Invest Hub View BCLI Investment Forum News - Investor Hub
Yahoo View BCLI Stock Mentions - Yahoo! Message Board Seeking Alpha View BCLI Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BCLI - SECform4.com Insider Cow View Insider Transactions for BCLI - Insider Cow
CNBC View BCLI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BCLI - OTC Markets
Yahoo View Insider Transactions for BCLI - Yahoo! Finance NASDAQ View Institutional Holdings for BCLI - NASDAQ


Stock Charts

FinViz View BCLI Stock Insight & Charts - FinViz.com StockCharts View BCLI Investment Charts - StockCharts.com
BarChart View BCLI Stock Overview & Charts - BarChart Trading View View BCLI User Generated Charts - Trading View




Latest Financial News for BCLI


BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA
Posted on Thursday January 10, 2019

NEW YORK and IRVINE, Calif., Jan. 11, 2019 -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly.


BCLI: Initiating Phase 2 Study in Progressive Multiple Sclerosis…
Posted on Monday January 07, 2019

On December 17, 2018, BrainStorm Cell Therapeutics, Inc. (BCLI) announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for testing NurOwn® in patients with progressive multiple sclerosis (MS). The company also announced that it has contracted with the Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute to expand production of NurOwn to support both the Phase 2 trial in MS as well as support ongoing production for the ongoing Phase 3 trial in amyotrophic lateral sclerosis (ALS).


BrainStorm Cell Therapeutics to Present at the 2019 Biotech Showcase and Sachs Associates Neuroscience Innovation Forum at JPM Week
Posted on Thursday January 03, 2019

NEW YORK, Jan. 03, 2019 -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today.


BrainStorm Issues 2018 Letter to Shareholders
Posted on Thursday December 27, 2018

BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issued a Letter to shareholders. This past year was an extraordinary success for BrainStorm Cell Therapeutics from a research and development, clinical, financial and corporate perspective.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.